Description
Lenvaxen 4mg (Lenvatinib) is a targeted cancer medication (tyrosine kinase inhibitor) used to treat progressive thyroid cancer, advanced liver cancer (hepatocellular carcinoma), and kidney cancer. It is manufactured by Everest Pharmaceuticals. The specific daily dosage depends on your cancer type and weight, and treatment is typically ongoing. [1, 2, 3, 4]
Key Details & Administration
- Dosage: While the capsule is 4mg, the total daily dose prescribed by your oncologist may vary. For example, thyroid cancer patients often take 24mg daily, while liver cancer dosing is weight-based (8mg or 12mg daily). [1]
- Missed Dose: If a dose is missed and cannot be taken within 12 hours, simply skip that dose and take your next dose at the regular scheduled time

Reviews
There are no reviews yet.